Nightstar Therapeutics to Participate in Multiple Conferences in November
08 Novembro 2018 - 9:05AM
Nightstar Therapeutics plc (NASDAQ:NITE), a clinical-stage gene
therapy company developing treatments for rare inherited retinal
diseases, today announced that the company will participate in the
following investor conferences in November.
- Jefferies London Healthcare Conference on Wednesday, November
14, 2018 at 12:40 p.m. GMT in London
- Barclays Gene Editing & Gene Therapy Summit on Thursday,
November 29, 2018 at 8:30 a.m. ET in New York City
The presentation at the Jefferies London Healthcare Conference
will be webcast. To access the live webcast, please visit
ir.nightstartx.com. A replay of the webcast will be available on
the Nightstar website for two weeks following the conference.
About NightstarNightstar is a leading
clinical-stage gene therapy company focused on developing and
commercializing novel one-time treatments for patients suffering
from rare inherited retinal diseases that would otherwise progress
to blindness. Nightstar’s lead product candidate, NSR-REP1, is
currently in Phase 3 development for the treatment of patients with
choroideremia, a rare, degenerative, genetic retinal disorder that
has no current treatments. Results from a Phase 1/2 trial of
NSR-REP1 were published in Nature Medicine in 2018,
in The New England Journal of Medicine in 2016, and
in The Lancet in 2014. Nightstar’s second product
candidate, NSR-RPGR, is currently being evaluated in a Phase 1/2
clinical trial for the treatment of patients with X-linked
retinitis pigmentosa, an inherited X-linked recessive retinal
disease. In September 2018, Nightstar announced preliminary safety
and efficacy data from the XIRIUS trial for the first five cohorts
(combined n=15) of the dose escalation study at the EURETINA
medical meeting.
For more information about Nightstar or its clinical trials,
please visit www.nightstartx.com.
Contact:Senthil Sundaram, Chief Financial
OfficerBrian Luque, Sr. Manager, Investor
Relationsinvestors@nightstartx.com
Nightstar Therapeutics Plc ADS (NASDAQ:NITE)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Nightstar Therapeutics Plc ADS (NASDAQ:NITE)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024
Notícias em tempo-real sobre Nightstar Therapeutics Plc ADS da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de